New Gene Therapy to Rescue Mini Retinas from Eye Disease Developed

Scientists have rescued mini retinas from eye disease retinitis pigmentosa via a new gene therapy approach.

A novel gene treatment that offers tremendous promise for treating retinitis pigmentosa, an eye disease that leads to blindness and affects thousands of people across the globe has been developed by scientists.

Researchers from Trinity College Dublin and University College London (UCL) teamed up to pool their expertise in genetics, virology and ophthalmology, beginning the journey towards a new treatment for a group of eye diseases collectively referred to as retinitis pigmentosa (RP). Their exciting results are published today in a leading journal, Stem Cell Reports.

Retinitis Pigmentosa - Causes, Symptoms, Diagnosis, Treatment & Complications
Retinitis pigmentosa is an inherited degenerative disorder which affects retina’s ability to respond to light. It results in progressive loss of vision, eventually leading to blindness.

‘Scientists have rescued mini retinas from eye disease via a new gene therapy approach.’

RP is a group of rare, genetic disorders that involve a breakdown and loss of cells in the retina, which is the light sensitive tissue that lines the back of the eye. Common early stage symptoms include difficulty seeing at night and a loss of side (peripheral) vision, with blindness often developing in time.

Scientists have known for some time that mutations in the gene 'RP2', which is responsible for making a protein essential for normal vision, are associated with RP diseases. However, there are currently no therapies to treat people living with a number of RP diseases.

The collaborative team behind the exciting new research used a modified common virus to deliver a normal, functioning copy of the RP2 gene into "mini retinas", which had been engineered from stem cells and which contained the defective version of the gene. The "mini retinas" developed in UCL simulated the RP2 disease in patients.

Test Your Knowledge on Gene Therapy
Gene Therapy - Potential Treatment for Incurable Diseases

Gene therapy is a novel procedure in which genetic material is introduced into a patient’s cells to replace a faulty gene in order to try and cure disease. It holds promise in the treatment of several diseases such as cystic fibrosis, hemophilia, heart disease and diabetes. Take this quiz to test your knowledge on gene therapy.

Subsequent analysis showed that these mini retinas had successfully taken up the functioning RP2 gene following the viral delivery and produced the essential protein associated with it. Crucially, the treated mini retinas showed significant improvement - underlining that the approach had rescued them from RP.

Immune System to Slow Degenerative Retinitis Pigmentosa
Complement system found to play a vital role to slow retinal degeneration in a mouse model of retinitis pigmentosa.

Ciara Shortall, PhD Researcher in Trinity's School of Genetics and Microbiology, is one of the main authors of the published study. Explaining the significance of the work, she said: "For the last 30 years there has been a lot of buzz about gene therapies and their potential for treating a huge variety of debilitating diseases and disorders, but it is really only recently that science has overcome difficulties associated with such approaches and begun to bring potential therapies far closer.

"In relative terms it is now fairly easy to replace troublesome genes with functioning versions using non-harmful viruses, which is what we have done here. And while we are still some time and a lot of work away from an approved therapy it is hugely exciting to have begun a journey that could one day provide an effective treatment to rescue eyesight."

Quiz on Eye Disorders (Advanced)
When your eye is the mirror to your soul, how can you ignore your eye health? Take this quiz to find out how much you know about the common eye disorders.

The Trinity team, led by Professor Jane Farrar, used their expertise in genetics and virus creation in the process, while the UCL team, led by Professor Michael Cheetham, took the lead in creating the mini retinas used to road-test the gene therapy.

Professor Cheetham said: "It is an important development that we can now reproduce so many elements of inherited disease using these mini-retinas. It makes it possible for us to study in detail why people go blind and try to find ways to prevent blindness. It's exciting that the gene therapy seems to be so effective for this form of RP."

Ocular research in Trinity College Dublin is supported by the Health Research Board of Ireland, Science Foundation Ireland, Fighting Blindness Ireland and Health Research Charities Ireland.

Source-Eurekalert